Insights on the Animal Pharmaceuticals Global Market to 2026 - Featuring Aratana Therapeutics, Bayer and Sanofi Among Others - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Animal Pharmaceuticals Market Research Report by Type, Product, Application, End-user, and Region - Global Forecast to 2026 - Cumulative Impact of COVID-19" report has been added to ResearchAndMarkets.com's offering.

The Global Animal Pharmaceuticals Market size was estimated at USD 16.45 billion in 2020, is expected to reach USD 17.68 billion in 2021, and projected to grow at a CAGR of 7.82% reaching USD 25.84 billion by 2026.

Competitive Strategic Window

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Animal Pharmaceuticals Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Animal Pharmaceuticals Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Animal Pharmaceuticals Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Animal Pharmaceuticals Market?

4. What is the competitive strategic window for opportunities in the Global Animal Pharmaceuticals Market?

5. What are the technology trends and regulatory frameworks in the Global Animal Pharmaceuticals Market?

6. What is the market share of the leading vendors in the Global Animal Pharmaceuticals Market?

7. What modes and strategic moves are considered suitable for entering the Global Animal Pharmaceuticals Market?

Market Dynamics

Drivers

• Rising adoption of pets across the globe
• Increasing cases of zoonotic and chronic diseases
• Livestock population experiencing rapid growth
• Government mandatory medication and vaccination

Restraints

• Several risk factors associated with animal health APIs

Opportunities

• Increasing awareness and expenditure among people regarding animal healthcare
• Development of new products
• Unmet animal needs in many countries

Challenges

• Limited awareness and availability in low-income areas

Companies Mentioned

• Aratana Therapeutics, Inc.
• Bayer AG
• BioPredic International
• Boehringer Ingelheim International GmbH
• Ceva Animal Health LLC - Biomune
• Ceva Sante Animale
• Dechra Pharmaceuticals PLC
• Dechra Veterinary Products USA
• Elanco Animal Health Inc.
• Eli Lilly & Company
• Huvepharma, Inc.
• Liberty Pharma INC
• Merck & Co. Inc.
• Perrigo Company plc
• Sanofi
• Sparhawk Laboratories
• Vetoquinol S.A.
• Virbac SA
• Zoetis Inc.

For more information about this report visit https://www.researchandmarkets.com/r/c60qy